BNP Paribas Arbitrage SNC |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
BNP Paribas Arbitrage SNC |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
ExodusPoint Capital Management Singapore, Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
Integrated Core Strategies (Asia) Pte. Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
JPM Securities Japan Co Ltd. |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
モルガン・スタンレーMUFG証券株式会社 |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |
三菱UFJモルガン・スタンレー証券株式会社 |
HISAMITSU PHARMACEUTICAL CO.,INC. |
Subscription Required |
Subscription Required |
Japan |